{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "15238705", "DateCompleted": {"Year": "2005", "Month": "02", "Day": "25"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "11"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0282-0080", "JournalIssue": {"Volume": "20", "Issue": "6", "PubDate": {"Year": "2004"}}, "Title": "Glycoconjugate journal", "ISOAbbreviation": "Glycoconj J"}, "ArticleTitle": "Preparation and immunological studies of protein conjugates of N -acylneuraminic acids.", "Pagination": {"StartPage": "407", "EndPage": "414", "MedlinePgn": "407-14"}, "Abstract": {"AbstractText": ["The overexpression of N -acetylneuraminic acid (Neu5Ac) is closely correlated with malignant transformations. Thus, Neu5Ac is an important target in the design of cancer vaccines. To study the influence of chemical modifications of Neu5Ac on its immunological properties, the alpha-allyl glycosides of five differently N -acylated neuraminic acid derivatives were prepared. Following selective ozonolysis of their allyl group to form an aldehyde functionality, they were coupled to keyhole limpet hemocyanin (KLH) via reductive amination. Resultant glycoconjugates were studied in C57BL/6 mice. The N -propionyl, N - iso- butanoyl and N -phenylacetyl derivatives of neuraminic acid provoked robust immune responses of various antibody isotypes, including IgM, IgG1, IgG2a and IgG3, whereas N -trifluoropropionylneuraminic acid and natural Neu5Ac were essentially nonimmunogenic. Moreover, the N -phenylacetyl and N - iso- butanoyl derivatives mainly induced IgG responses that are desirable for antitumor applications. These results raise the promise of formulating effective glycoconjugate cancer vaccines via derivatizing sialic acid residues of sialooligosaccharides."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA."}], "Identifier": [], "LastName": "Chefalo", "ForeName": "Peter", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pan", "ForeName": "Yanbin", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nagy", "ForeName": "Nancy", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Harding", "ForeName": "Clifford", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Guo", "ForeName": "Zhongwu", "Initials": "Z"}], "GrantList": [{"GrantID": "R01 CA095142-03", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "1R01 CA95142", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA095142-02", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA095142", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA095142-04", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA095142-01", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Glycoconj J", "NlmUniqueID": "8603310", "ISSNLinking": "0282-0080"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cancer Vaccines"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycoconjugates"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin G"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin M"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuraminic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Oligosaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Sialic Acids"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9013-72-3", "NameOfSubstance": "Hemocyanins"}, {"RegistryNumber": "FV4Y0JO2CX", "NameOfSubstance": "keyhole-limpet hemocyanin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cancer Vaccines"}, {"QualifierName": [], "DescriptorName": "Carbohydrate Sequence"}, {"QualifierName": [], "DescriptorName": "Cell Transformation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glycoconjugates"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hemocyanins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Immunoglobulin G"}, {"QualifierName": ["chemistry"], "DescriptorName": "Immunoglobulin M"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Models, Chemical"}, {"QualifierName": ["chemical synthesis", "chemistry", "immunology"], "DescriptorName": "Neuraminic Acids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Oligosaccharides"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sialic Acids"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Brinkman-Van der Linden ECM, Sjoberg ER, Juneja LR, Crocker PR, Varki N, Varki A. Loss of N-glycolylneuraminic acid in human evolution. J. Biol. Chem. 2000;275:8633\u20138640.", "ArticleIdList": ["10722703"]}, {"Citation": "Schauer R. Sialic acids as antigenic determinants of complex carbohydrates. Adv. Exp. Med. Biol. 1988;228:47\u201372.", "ArticleIdList": ["2459931"]}, {"Citation": "Reutter W, Stasche R, Stehling P, Baum O. The biology of sialic acids: insights into their structure, metabolism and function in particular during viral infection. In: Gabius H-J, Gabius S, editors. Glycosciences. Chapman & Hall; Weinheim: 1997. pp. 245\u2013259."}, {"Citation": "Wagner M. Sialic acid-specific lectins. Adv. Lectin Res. 1990;3:36\u201382."}, {"Citation": "Varki A. Sialic acids as ligands in recognition phenomena. FASEB J. 1997;11:248\u2013255.", "ArticleIdList": ["9068613"]}, {"Citation": "Crocker PR. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr. Opin. .Struct. Biol. 2002;12:609\u2013615.", "ArticleIdList": ["12464312"]}, {"Citation": "Von Itzstein M, Thomson RJ. Sialic acids and sialic acid-recognizing proteins: drug discovery targets and potential glycopharmaceuticals. Curr. Med. Chem. 1997;4:185\u2013210."}, {"Citation": "Takano R, Muchmore E, Dennis JW. Sialylation and malignant potential in tumor cell glycosylation mutants. Glycobiology. 1994;4:665\u2013674.", "ArticleIdList": ["7881181"]}, {"Citation": "Hakomori S. Tumor-associated carbohydrate antigens and modified blood group antigens. In: Montreuil J, Vliegenthart JFG, Schachter H, editors. Glycoproteins and Disease. Elsevier; Amsterdam: 1996. pp. 243\u2013276."}, {"Citation": "Ragupathi G. Carbohydrate antigens as targets for active specific immunotherapy. Cancer Immunol. Immunother. 1998;46:82\u201387.", "ArticleIdList": ["9001568"]}, {"Citation": "Hakomori S, Zhang Y. Glycosphingolipid antigens and cancer therapy. Chem. Biol. 1997;3:97\u2013104.", "ArticleIdList": ["9190292"]}, {"Citation": "Helling F, Shang A, Calves M, Zhang S, Ren S, Yu RK, Oettgen HF, Linvingston PO. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res. 1994;54:197\u2013205.", "ArticleIdList": ["8261439"]}, {"Citation": "Unverzagt C. Chemoenzymatic synthesis of a sialylated undecasaccharide-asparagine conjugate. Angew. Chem., Intl. Ed. Eng. 1996;35:2350\u20132353."}, {"Citation": "Blixt O, Norberg T. Solid-phase enzymatic synthesis of a sialyl Lewis X tetrasaccharide on a sepharose matrix. J. Org. Chem. 1998;63:2705\u20132710.", "ArticleIdList": ["11672140"]}, {"Citation": "Chappell MD, Halcomb RL. Enzyme-catalyzed synthesis of oligosaccharides that contains functionalized sialic acids. J. Am. Chem. Soc. 1997;119:3393\u20133394."}, {"Citation": "Ichikawa Y, Shen GJ, Wong CH. Enzyme-catalyzed synthesis of sialyl oligosaccharide with in situ regeneration of CMP-sialic acid. J. Am. Chem. Soc. 1991;113:4698\u20134700."}, {"Citation": "Ichikawa Y, Liu JLC, Shen GJ, Wong C-H. A highly efficient multienzyme system for the one-step synthesis of a sialyl trisaccharide: in situ generation of sialic acid and N-acetyllactosamine coupled with regeneration of UDP-glucose, UDP-galactose and CMP-sialic acid. J. Am. Chem. Soc. 1991;113:6300\u20136302."}, {"Citation": "Bertozzi CR, Kiessling LL. Chemical glycobiology. Science. 2001;291:2357\u20132364.", "ArticleIdList": ["11269316"]}, {"Citation": "Saxon E, Bertozzi CR. Cell surface engineering by a modified Staudinger reaction. Science. 2000;287:2007\u20132010.", "ArticleIdList": ["10720325"]}, {"Citation": "Mahal LK, Bertozzi CR. Engineering cell surfaces: fertile ground for molecular landscaping. Chem. Biol. 1997;4:415\u2013422.", "ArticleIdList": ["9224572"]}, {"Citation": "Yarema KJ, Mahal LK, Bruehl RE, Rodriguez EC, Bertozzi CR. Metabolic delivery of ketone groups to sialic acid residues. Application to cell surface glycoform engineering. J. Biol. Chem. 1998;273:31168\u201331179.", "ArticleIdList": ["9813021"]}, {"Citation": "Mahal KL, Yarema KJ, Bertozzi CR. Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science. 1997;276:1125\u20131128.", "ArticleIdList": ["9173543"]}, {"Citation": "Kayser H, Geile CC, Paul C, Zeitler R, Reutter W. Incorporation of N-acyl-2-amino-2-deoxy-hexoses into glycosphingolipids of pheochromocytoma cell line PC12. FEBS. 1992;301:137\u2013140.", "ArticleIdList": ["1568471"]}, {"Citation": "Schmidt C, Stehling P, Schnitzer J, Reutter W, Horskorte R. Biological engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor. J. Biol. Chem. 1998;273:19146\u201319152.", "ArticleIdList": ["9668100"]}, {"Citation": "Liu T, Guo Z, Yang Q, Sad S, Jennings HJ. Biochemical engineering of surface \u03b1(2-8)polysialic acid for immunotargeting cancer cells. J. Biol. Chem. 2000;275:32832\u201332836.", "ArticleIdList": ["10976100"]}, {"Citation": "Lemieux GA, Bertozzi CR. Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens. Chem. Biol. 2001;8:265\u2013275.", "ArticleIdList": ["11306351"]}, {"Citation": "Jennings H. N-propionylated group B meningococcal polysaccharide glycoconjugate vaccine against group B meningococcal meningitis. Int. J. Infect. Dis. 1997;1:158\u2013164."}, {"Citation": "Jennings HJ, Sood RK. Synthetic glycoconjugates as human vaccines. In: Lee YC, Lee RT, editors. Neoglycoconjugates: Preparation and Applications. Academic Press; San Diego: 1994. pp. 325\u2013371."}, {"Citation": "Ritter G, Boosfeld E, Calves MJ, Oettgen HF, Old LJ, Livingston PO. Antibody response after immunization with ganglioside GD3, GD3 lactones, GD3 amide and GD3 gangliosidol in the mouse. GD3 lactone I induces antibodies reactive with human melanoma. Immunobiology. 1990;182:32.", "ArticleIdList": ["2098322"]}, {"Citation": "Ritter G, Boosfeld E, Asluri S, Calves MJ, Oettgen HF, Old LJ, Livingston PO. Antibody response after immunization with ganglioside GD3, GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. Int. J. Cancer. 1991;48:379\u2013385.", "ArticleIdList": ["2040532"]}, {"Citation": "Roy R, Laferriere C. Synthesis of protein conjugates and analogs of n-acetylneuraminic acid. Can. J. Chem. 1990;68:2045\u20132054."}, {"Citation": "Svennerholm L. Estimation of sialic acids. II. Colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta. 1957;24:604\u2013611.", "ArticleIdList": ["13436486"]}, {"Citation": "Guo Z, Jennings HJ. Protein-polysaccharide conjugation. Methods in Molecular Medicine. 2001;66:49\u201354. Meningococcal Vaccines.", "ArticleIdList": ["21336746"]}, {"Citation": "Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985;314:537\u2013539.", "ArticleIdList": ["3157869"]}, {"Citation": "Evans JT, Cluff CW, Johnson DA, Lacy MJ, Persing DH, Baldridge JR. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev. Vaccines. 2003;2:219\u2013229.", "ArticleIdList": ["12899573"]}, {"Citation": "Casadevall A, Pirofski LA. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol. 2003;24:474\u2013478.", "ArticleIdList": ["12967670"]}, {"Citation": "Danishefsky SJ, Allen JR. From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines. Angew. Chem. Int. Ed. 2000;39:837\u2013863.", "ArticleIdList": ["10760879"]}, {"Citation": "Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Antibodies: Structure and function. In: Freeman WH, editor. Fundamental Immunology. Company; New York, N.Y.: 2003. pp. 76\u2013105."}, {"Citation": "Ravetch JV, Kinet JP. Fc eeceptors. Annu. Rev. Immunol. 1991;9:457\u2013492.", "ArticleIdList": ["1910686"]}, {"Citation": "Pan Y, Ayani T, Nadas J, Guo Z. Accessibility of N-acyl derivatives of D-mannosamine to N-acetylneuraminic acid aldolase. 2004. submitted.", "ArticleIdList": ["PMC3177532", "15280054"]}, {"Citation": "Jacobs CL, Goon S, Yarema KJ, Hinderlich S, Hang HC, Chai DH, Bertozzi CR. Substrate specificity of the sialic acid biosynthetic pathway. Biochemistry. 2001;40:12864\u201312874.", "ArticleIdList": ["11669623"]}]}], "History": [{"Year": "2004", "Month": "7", "Day": "9", "Hour": "5", "Minute": "0"}, {"Year": "2005", "Month": "2", "Day": "26", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "7", "Day": "9", "Hour": "5", "Minute": "0"}, {"Year": "2011", "Month": "9", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15238705", "NIHMS325281", "PMC3178808", "10.1023/B:GLYC.0000033997.01760.b9", "5276735"]}}], "PubmedBookArticle": []}